Press Release July 23, 2021Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against AcelRx Pharmaceuticals, Inc. (ACRX) 0 0 Share
Press Release July 21, 2021The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of AcelRx Pharmaceuticals, Inc. (ACRX) Investors 0 0 Share
Press Release July 18, 2021SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in AcelRx Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadline - ACRX 0 0 Share
Press Release July 18, 2021SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in AcelRx Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadline - ACRX 0 0 Share
Press Release July 17, 2021ACRX ALERT: ROSEN, SKILLED INVESTOR COUNSEL, Encourages AcelRx Pharmaceuticals, Inc. Investors to Secure Counsel Before Important August 9 Deadline in Securities Class Action - ACRX 0 0 Share
Press Release July 16, 2021ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages AcelRx Pharmaceuticals, Inc. Investors to Secure Counsel Before Important August 9 Deadline in Securities Class Action – ACRX 0 0 Share
Press Release July 14, 2021ROSEN, A LEADING LAW FIRM, Encourages AcelRx Pharmaceuticals, Inc. Investors to Secure Counsel Before Important August 9 Deadline in Securities Class Action - ACRX 0 0 Share
Company Ticker News July 14, 2021AcelRx, Aguettant Ink Licensing Agreements For Dzuveo And Two Prefilled Syringe Products 0 0 Share
Press Release July 14, 2021AcelRx Enters into Licensing Agreement for DZUVEO® in Europe and In-licensing Agreement for Two Products in the U.S. 0 0 Share
Press Release July 10, 2021SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in AcelRx Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadline - ACRX 0 0 Share
